Sutezolid

CAS : 168828-58-8

Ref. 3D-TGA82858

Informations sur le produit

• Nom: Sutezolid
• Synonymes: (S)-N-((3-(3-Fluoro-4-thiomorpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, Acetamide, N-[[3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-, N-({(5S)-3-[3-fluoro-4-(thiomorpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide, N-[[(5S)-3-[3-Fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, Pnu 100480, U 100480, acetamide, N-[[(5S)-3-[3-fluoro-4-(4-thiomorpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-

Description

Sutezolid is a novel, orally bioavailable and broad-spectrum antibiotic that inhibits bacterial growth by inhibiting fatty acid synthesis. Its mechanism of action is similar to other antibiotics in the class, including linezolid and ethylene diamine. Sutezolid has been shown to be effective against tuberculosis in CD-1 mice. It binds to the 16S ribosomal RNA of Mycobacterium tuberculosis and inhibits the production of essential fatty acids required for bacterial growth. This drug also has a strong inhibitory effect on the synthesis of mycolic acids, which are key components of mycobacterial cell walls.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 353.41 g/mol
• Formule: C₁₆H₂₀FN₃O₃S
• Degré de pureté: Min. 95%